These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 3218975
1. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224). Gosse C, Atassi G, Letourneux Y, Ardouin P, Gouyette A, Fournier JP, Roger P. Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975 [Abstract] [Full Text] [Related]
4. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals. Imbach JL, Montero JL, Moruzzi A, Serrou B, Chenu E, Hayat M, Mathe G. Biomedicine; 1975 Dec 20; 23(10):410-3. PubMed ID: 1222217 [Abstract] [Full Text] [Related]
9. Formulation of three nitrosoureas for intravenous use. Davignon JP, Yang KW, Wood HB, Cradock JC. Cancer Chemother Rep 3; 1973 May 20; 4(3):7-11. PubMed ID: 4201309 [No Abstract] [Full Text] [Related]
10. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride. Fujimoto S, Ogawa M, Sakurai Y. Cancer Res; 1982 Oct 20; 42(10):4079-85. PubMed ID: 6955008 [No Abstract] [Full Text] [Related]
11. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides. Brundrett RB, Colvin M, White EH, McKee J, Hartman PE, Brown DL. Cancer Res; 1979 Apr 20; 39(4):1328-33. PubMed ID: 421216 [Abstract] [Full Text] [Related]
13. Biologic activity of MCNU: a new antitumor agent. Sekido S, Ninomiya K, Iwasaki M. Cancer Treat Rep; 1979 Jun 20; 63(6):961-70. PubMed ID: 466655 [Abstract] [Full Text] [Related]
14. Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenografts. Dumont P, Atassi G, Roger P. In Vivo; 1990 Jun 20; 4(1):61-4. PubMed ID: 2103843 [Abstract] [Full Text] [Related]
15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR. Clin Cancer Res; 1997 Nov 20; 3(11):2063-74. PubMed ID: 9815598 [Abstract] [Full Text] [Related]
16. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors. Akaike Y, Arai Y, Taguchi H, Satoh H. Gan; 1982 Jun 20; 73(3):480-7. PubMed ID: 7129012 [Abstract] [Full Text] [Related]
18. Biological activity of hydroxylated chloroethylnitrosoureas. Zeller WJ, Frühauf S, Chen G, Eisenbrand G, Lijinsky W. Cancer Res; 1989 Jun 15; 49(12):3267-70. PubMed ID: 2720679 [Abstract] [Full Text] [Related]
19. O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia. D'Incalci M, Taverna P, Erba E, Filippeschi S, Potenza D, Mariani L, Citti L, Catapano CV. Anticancer Res; 1991 Jun 15; 11(1):115-21. PubMed ID: 2018345 [Abstract] [Full Text] [Related]
20. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent. Schein PS, Panasci L, Woolley PV, Anderson T. Cancer Treat Rep; 1976 Jun 15; 60(6):801-5. PubMed ID: 133756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]